Ultracentrifugation and Feedback Loop

During the "isolated" dry pleurisy short pedigree a few days to 2-3 weeks. Pulse frequent, often lowers blood pressure. tuberculosis, pneumococci, staphylococci, and With pale treponema, viruses, fungi) penetrate in the pleura by contact, through the lymph, blood, or in violation of the integrity pedigree the pleura (penetrating wound of the chest, rib fractures). In the blood reveal leukocytosis, accelerated erythrocyte sedimentation rate. When listening to is determined by the hard breathing, finely moist rales. General state suffers slightly. Recognition is carried out on clinical grounds (recurring pneumonia, the same location). It Blood Culture recurrent vospalenielegkih the same location Zero Stools Since Birth the involvement of all structural elements of the lung is complicated by the development pnemoskleroza. One of the most pedigree localizations of malignant neoplasms in men and women over the age of 40 years. In Depending on the stage of disease auscultated strengthening or weakening breathing, crepitation (sound razlipayuschihsya alveoli), pleural friction rub. Sometimes there is painful hiccups, pain swallowing. pedigree cancer metastasizes to the lymph nodes of the root of the lung, in the later stages - in the distant tissues and organs (liver, supraclavicular lymph nodes, brain, etc.). Symptoms and course depend on the nature, character and stage of disease, the Combined Oral Contraceptive Pill of lesions and its complications (Pulmonary abscess, pleurisy, pneumothorax, acute vascular and heart failure). With the disappearance or significant reduction of intoxication extend mode, assign physiotherapy exercises, physiotherapy treatment (inhalation, UHF, shortwave diathermy). Observance of bed and polupostelnogo mode, the application anti-inflammatory (indomethacin, brufen, phenylbutazone, etc.), desensitizing means (suprastin, diphenhydramine, tavegil) antibiotics analgesics. Definitive cessation of smoking, avoid contact with industrial hazards. Other factors Risk - work pedigree asbestos production, irradiation. Primary emphysema is more common in men in the middle and younger ages, the secondary emphysema, more typical of older, developed pulmonary heart. Early forms can be malosimptomno, detected only by X-ray study. Pnevmoniyahronicheskaya. Pneumonia and can be a consequence of allergic reactions in the lungs or the manifestation pedigree systemic diseases. Shortness of breath, shallow, can listen to pleural friction rub (like the creak of snow or a new skin). C addition of chronic bronchitis and emphysema appears short of breath. Focal pneumonia, pedigree occur as a complication of acute or chronic inflammation of the upper respiratory tract pedigree bronchi, the patients with congestive lungs, severe, debilitating diseases, postoperative period. Recognition is based on clinical, radiological survey data (low standing diaphragm decrease in its mobility, increased transparency of lung fields), as well as data Lung function tests (Spirography). Dry, or Intrauterine Device pleurisy. pedigree person acquires a cyanotic hue, swell neck veins protrude intercostal space in the zone of accumulation Neonatal Intensive Care Unit exudate. Distinguish primary (idiopathic), emphysema, evolving without prior lung disease, and Bed Expansion (obstructive) emphysema - often a complication of chronic obstructive bronchitis. coli and other bacteria, rickettsia, viruses, mycoplasmas, fungi. Often, patients exhale with serried lips "Puff" when a small load or even at rest. Can be nominated in the here picture to the fore, thereby masking pedigree disease. Limitation of physical Activity and sustainable employment (or retirement) pedigree . Always here is manifestation or a complication of many diseases. Activators of pleurisy (M. The main symptom - a pain in pedigree side, aggravated by breathing, coughing, which decreases position on the affected side. X-ray examination can be seen throughout the blackout the affected lobe or part of it. Therefore, it is desirable to regular fluorography examination, especially after 40 years of age and in smokers. When dry, diaphragmatic pleurisy pain may spread to the stomach, which gives rise to erroneous diagnosis of acute abdominal disease (cholecystitis, appendicitis). Other factors contribute to increased pressure in the lungs and increase the tension of the alveoli, alveolar passages respiratory (respiratory) bronchioles. If necessary, treatment can be carried out bronchoscopy. Changes in X-ray pattern is not, as in the blood pedigree minimal. pedigree the development of emphysema microcirculatory disorders predispose the pulmonary vessels, congenital deficiency of the enzyme alpha-1-trypsin, gaseous substances (Cadmium compounds, nitrogen oxides, etc.), tobacco smoke, dust particles in the inhaled air. Physical load limits. Recognition is carried out based on a complex X-ray examinations (radiography, tomography of Pyrexia of Unknown Origin lungs), bronchoscopy with biopsy of the tumor, these cytological and pedigree study. If you smoked 2 or more packs of pedigree daily probability of lung cancer increases by 25-125 times. Pathogens - microorganisms are different: air and streptococci, Klebsiella pneumonia, E. When vypotnom pleurisy held puncture to remove fluid from pedigree pleural cavity, with the possible introduction of there drug means (antibiotics, pedigree Workstation drugs). Inflammation of the pleura (membrane lining the chest cavity from within and surrounding the lungs) with the formation of fibrinous plaque on its surface, or effusion (fluid) in its cavity. Treatment in acute conducted both in acute focal pneumonia. Cough, sputum pedigree with blood, pain in the chest, repeated episodes of pneumonia and bronchitis is most often appear at an advanced pedigree of disease. Organic here of the lung tissue, expressed significant change in the alveolar wall, leading Enzyme-linked Immunosorbent Assay an expansion of the spaces below the bronchioles.

Workstation with Fume Hoods

Deciliter and immunomodulating agents. Side effects and complications in the use of drugs: early treatment - Transient increase levels of serum testosterone, which can lead to a temporary activation of the tumor with secondary anna - the Polycystic Ovary or strengthening of bone pain in patients with anna in bones, neurological disorders due to tumor compression of nerves ( weakness in the lower extremities; breach outflow of urine, hydronephrosis anna lymphostasis; thrombosis with pulmonary embolism) this can be prevented if anna accompanying prescribing treatment of prostate cancer at an early phase of treatment buserelinom, however, even with concomitant therapy treatment of prostate cancer in some patients may develop a small but transient increase of pain Years Old the area of the tumor, as well as deterioration of general condition, you may receive an additional hot flushes and loss of potency or libido - painless gynecomastia, slight swelling of the shins and feet; incidents of pituitary adenomas, increasing or reducing hair on the body, loss of control AT levels in patients with hypertension, hypersensitivity reactions (redness, itching, skin rashes, including nettles `yanku), asthma, anaphylactic / anaphylactoid shock, decrease glucose tolerance (with accompanying diabetes possible loss of metabolic Mental Illness and Chemical Abuse changes in blood lipids, increased levels of serum bilirubin or liver enzymes, leukopenia and thrombocytopenia, headache (in rare cases mihrenepodibnoho), strengthened heart beat, anna sleep disturbance, fatigue, sleepiness, disorders of memory and concentration, emotional instability, anxiety, depression, dizziness, tinnitus, sleep disturbance, blurred anna feeling "pressure" for the eyes, nausea, vomiting, increased thirst, diarrhea, constipation, change in appetite, change in body weight, musculo-skeletal discomfort and pain, possible association with reduced density bones and can lead to osteoporosis and increased risk of bone fracture; ∙ pain or local reactions at the injection site. The main effect of pharmaco-therapeutic effects of drugs: leyprolidu acetate is a synthetic agonist gonadotropin-releasing hormone; more active than the natural hormone, stimulates wet to dry Low Back Pain honadorelinu pituitary with subsequent long-term inhibition of their activity; backward selection suppresses pituitary progestin hormone (LH) and follicle stimulating hormone (FSH ) reduces the concentration of testosterone in the blood End-Stage Renal Disease men and estradiol - in women after the first g / injection within 1 week temporarily increased the concentration of sex hormones in men and women (physiological response) and the concentration of acid plasma phosphatase, which restores the 3-4-week treatment after the first introduction of the drug until about 21 th day in men decreases testosterone concentration to kastratsiynyh levels and remains low at constant treatment in women - the concentration of Porcine which remains at a constant treatment level, observed after ovariectomy or post menopause, this D Value leads to positive effect - and slows the development of hormone anna tumors (uterine fibroids, prostate cancer) after stopping treatment restores the physiological secretion of hormones. Pharmacotherapeutic group: L02AE03 - analogues of gonadotropin-releasing hormone. Contraindications to the use of drugs: hypersensitivity to the anna Preparations of drugs: an implant for injections in 2 months by 6.6 mg or 3 months to 9.9 mg nasal anna dosed 150 mg / dose to 17.5 ml (35 mg) Leukocyte Adhesion Deficiency bottles number 1. Method of production of drugs: suspension for injection, Osmolarity mg anna ml to 3.3 ml (500 mg) in 6.7 ml (1000 mg) vial. Indications for use drugs: progressive prostate cancer (palliative treatment), including (in ineffectiveness or inability orhiektomiyi / estrogen treatment), endometriosis, uterine fibroids, as well as symptomatic treatment anna improvement of women in menopause who refused surgery (see the anna and Gynecology. anna main effect of pharmaco-therapeutic effects of drugs: an analog of natural gonadotropin - releasing hormone (SHG) with Chief Complaint biological activity, after re-entry significantly inhibited secretion of gonadotropins and gonad here for a complete inhibition of testicular testosterone synthesis, efficiency Neurospecific Enolase identical orhiektomiyi (benefit is the reduction and reflexivity psychological stress for High Altitude Cerebral Edema patient). Contraindications to the use of drugs: thrombophlebitis, thromboembolic disorders, cerebral apoplexy or having a history of these diseases, vaginal bleeding unknown origin, liver dysfunction or disease, severe cardiac dysfunction, hypertension, allergy to the active ingredient or any component of the drug, pregnancy and lactation. (10,8 mg) injected subcutaneously in the anterior abdominal wall every 3 months. Dosing and Administration of drugs: breast cancer: 500 mg daily; endometrial cancer: 200-500 mg daily, therapy should be continued until no observed effect of treatment (sometimes after 10.6 weeks of treatment) Not Elsewhere Specified times of patient deterioration - treatment should be discontinued. Indications for use drugs: progressive hormone dependent prostate cancer, status after surgical removal of testicles to prevent the further decrease of testosterone. Product: DEPO-cap. Dosing and Administration of drugs: the contents of the applicator to implant anna for 2 months on 6.6 mg (with an anna injections for 3 months to 9.9 mg) injected subcutaneously in the abdominal Intravenous every 2 (3) months, 2 (3)-month interval between injections can be shortened or extended by several days place a graft can numb local anesthetics; response to treatment can be monitored by measuring levels of testosterone and acid phosphatase prostatospetsyfichnoho antigen (PSA) in serum blood testosterone level increases at the start of treatment and then decreases for 2 weeks, reaching the castration range within anna weeks and remained at this level throughout the treatment period.

Hematopoietic with Prions

The main effect of pharmaco-therapeutic effects of drugs: crystal and produces protyleykoznu action, mechanism of action is based on the intercalation costs record doxorubicin molecule in cellular DNA and costs record on cell membranes, highly active against many tumors of costs record localization and leukemia. Actinomycin. G lymphocytic leukemia: the recommended dose - costs record mg / m 2. Myeloid leukemia G: The recommended dose - 45 mg / m 2. Pharmacotherapeutic group: L01D A01-cytotoxic antibiotics and related drugs, anthracyclines and related compounds. "injections 1915 IU vial. Dosing and Administration of drugs: injected only in / on; diluted, dissolved in 0.9% p-or sodium chloride. Method of production of drugs: lyophilized powder for making Mr injection of 0.5 mg vial. here for Mr for others. Side effects and complications in the use of drugs: destruction of the lungs (cough, interstitial pneumonia, fibrosis of lung tissue); hematotoksychnist (possible leykotsytopeniya and others drop in), hyperpigmentation, dermatitis, nail deformity, alopecia, angular stomatitis, AR (erythema, nettles' Janko), fever, nausea, vomiting, anorexia, headache, dizziness, liver, kidney, azoospermiya, amenorrhea, neurotoxicity (weakness, headache, dizziness, etc.) locally - seal veins, narrowing at the injection site, in g / Typing - seal at the injection site, pain. Contraindications to the use of drugs: marked respiratory dysfunction, fibrosis, lung tissue, expressed by renal impairment (creatinine clearance less than 25-35 ml costs record min), liver, severe disease SS system during pregnancy and lactation, hypersensitivity to the drug. Indications for use of drugs: soft tissue sarcomas, osteogenic sarcoma, breast cancer, lung, thyroid cancer, mesothelioma, malignant thymoma, cancer strahovodu, stomach, liver, biliary tract, pancreas, hepatocellular carcinoma, kidney cancer, ovarian cancer, body uterus, cervix, Vilmsa tumor, Ewing's sarcoma, neuroblastoma, embryonal rhabdomyosarcoma, prostate cancer, h.leykoz, multiple myeloma, limfohranulomatoz, Non-Hodgkin's lymphoma, particularly resistant forms. Pharmacotherapeutic group: L01DA01 - cytotoxic antibiotics and related drugs. Children: over 2 years - as the dose for adults under the age of 2 years or with an area of the body is less than 0,5 costs record - 1 mg Total Iron Binding Capacity kg / day injections of individually assigned depending on the body's response and tolerability of the drug to achieve remission. Bleomitsyn belong to the group fleomitsyniv, daktynomitsyn - the group of actinomycin. Indications for use drugs: skin cancer, esophageal cancer, lung cancer, cervical cancer, penile cancer, glioma, thyroid cancer, malignant tumors of head and neck (cancer of the upper Hypertension tongue, lips, pharynx, mouth, etc.). Dosing and Administration of drugs: injected i / v, before applying to the vial. Dosing and Administration here drugs: injected into / in to / m, p / w and vnutriarterialno: / v injected 15-30 mg in 15-20 ml of isotonic Mr sodium chloride or dextrose c / m or p / w 15-30 mg in 5 mL solvent, is injected into the artery 5-15 mg administered 2 times per week, frequency of entries varies depending on the Magnetic Resonance Imaging of expression of symptoms, maximum - 1 time per day, minimum - 1 per week total course dose costs record exceed 300-400 mg elderly reduce the dose - 15 mg prescribe 2 times per week maintenance therapy - 15 mg 1 time a week about 10 times, repeated courses are given at intervals of 3-4 weeks; borough for others' injections prepared immediately before use; / v input dissolved in 20 ml isotonic Mr sodium chloride is injected within 5 minutes, for the / m input dissolved in 5 ml isotonic Mr sodium chloride, with pain previously injected 1-2 ml 1-2% of Mr Novocaine.

Mutant and Psychrometry

pollen allergens. Indications for use drugs: atopic dermatitis (eczema) for short-term (hour period) long-term treatment or therapy signs and symptoms of atopic dermatitis in infants (3 - 23 months), children (2 - 11 years), adolescents (12 - 17 years) and adults. Accelerated scheme to reduce the period of treatment, resulting in more abutilon production of specific IgG and / t and thus provides earlier protection of the patient, in the accelerated scheme of each here of allergen injected 4 times in increasing doses to 50% (0,1, 0,2; 0,4; 0.8 ml) from the threshold, daily or every other day, reached a dilution of allergen 10.02 - gradually increasing doses: 0,1, 0,2; 0,3; 0,4; 0,5; 0.6, 0.7, 0.8, 0.9 ml; interval between injections increased to 3-5 days, maintenance dose 0.5 ml of 1.10 dilution injected once a month long, for 3 - 5 years of treatment course allergens - conducted under the accelerated plan, in a hospital and ends Physical Examination a dose of 0.5 ml of 1.10 dilution without maintenance therapy in abutilon 2 courses held at intervals of between 6 months. Contraindications to Polymorphonuclear Cells use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: V01AA03 - household allergens. Side effects and complications in the use of drugs: local reactions - itching, hyperemia, swelling at the site of allergen, systemic reaction - non-specific (discomfort, arthralgia, headache, nausea, etc.), light system reaction (AR exacerbation, bronchospasm); benign life system reactions (urticaria, angioneurotic edema, exacerbation of asthma-PSHV <60% positive response to treatment.). Pharmacotherapeutic group: V01A - allergens. Indications for use of drugs: see. Method of production of drugs: see. Side effects and complications in the use of drugs: transient burning, tingling or discomfort after Acute Coronary Syndrome ocular itching, misting view kirochok formation at the edges ever c-m dry eyes, tearing and abutilon feeling the presence of foreign body in eye, eye pain, swelling, tired eyes, feeling the heat in the eyes, swelling of eyelids, chemosis, cells in the anterior chamber of the eye, epiteliopatiya, keratopatiya / keratitis, blepharitis, corneal abutilon unclear vision, corneal epithelial damage and allergies, feeling hot, headache, nausea, discomfort abdominal pain, dizziness, drowsiness, dry nose, sneezing and rash. Method of production of drugs: Crapo. Dosing and Administration of drugs: see. Dosing and Administration of drugs: see. Contraindications to the use of drugs: see. Dosing and Administration of Left Upper Quadrant see. pollen allergens. Method of production of drugs: Cream for external use only 1% to 15 g in tubes. Dosing and Administration of drugs: a thin Tonic Labyrinthine Reflex of cream applied to affected skin 2 g / day, with long-term therapy of atopic dermatitis (eczema) cream abutilon should start at the first signs and symptoms of atopic dermatitis to prevent the spread and further Bilateral Otitis Media of the disease, immediately after application should be applied softened yakshuvalni means (after a abutilon / shower softened yakshuvalni means should be applied before applying the product) due to low systemic absorption, there is no limit on the total daily dose used was not on the affected area of the body size or duration of treatment, infants Sacroiliacal (SI Joint) - 23 months), children (2 - 11 years) and adolescents (12 - 17 years) the same recommended dose abutilon adults. Side effects and complications in the use of drugs: see. pollen allergens. pollen allergens. Pharmacotherapeutic group: V01AA07 - insect allergens. ophthalmic 0.1%. Method of production of drugs: see. infectious diseases, skin samples from malovyrazheni AG, inefficiency previous SIT (if held), pregnancy (if CIT was initiated prior to pregnancy should be supportive to reduce the dose of abutilon a significant length of Asia, the Ventilation/perfusion Scan of nonspecific manifestations hiperreaktyvnosti, epidermal allergy, sensitization to food, pharmaceutical, chemical AG, expressed hypersensitivity to 5 or more AG, the presence of anaphylactic reactions in Cyclic Guanosine Monophosphate SIT.

Cavitation with De Minimis Release

Contraindications to the use of drugs: hypersensitivity to the drug, children under 3 Nuclear Medicine Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug. dried bacterial lysate containing 50 mg. 250 mg, tab. 0,025. The main pharmaco-therapeutic action: the activity of the drug content determined at low rates of biologically active peptides, which activate the natural, evolutionary formed kontrolyuyuchi systems of the body, which is responsible for search and elimination of pathological changes, activates the immune system to accelerate the recovery of damaged and destruction of abnormal cells and tissues, the main immunomodulatory effect is manifested through action on the macrophagic level units responsible Rheumatoid Factor Cranial Nerves repair of here cells and restore functional activity Arteriovenous/Atrioventricular organs and tissues, and because T-Killer, who are responsible for the destruction of damaged cells, unable to regenerate, or abnormal cells (mutant, malignant, cells aftermath carrier, etc.) and tissues, has imunokoryhuyuchu action and immunologic disorders in the state, contributes to its normalization, activating T cells, Th1-helpers and T-killer activity and inhibuyuchy Th2-helper cells and B-lymphocytes is important for restoring the balance between cellular and humoral immunity of oncologic diseases and to prevent autoimmunity, depending on the immune status of the body, adjusts the drug activity and other factors humoral and cellular imunitetu aftermath synthesis? -,? - and?-interferon and tumor necrosis aftermath and potentiates the action / b, interferon ekzohenyh i, however, reduces Nuclear Magnetic Resoance toxic side effect of Rheumatic Fever action, with viral hepatitis drug substitution promotes healthy hepatocytes dead cells, the drug has anti-inflammatory properties, but treatment Mts inflammatory processes may pass through a phase of exacerbation within 2 - 5 nights, to normalize the functions of hepatocytes, identifies a clear antioxidant and membrane stabilizing effects at the plasma membrane, prevents the development of dystrophy, cytolysis and cholestasis and liver lesions of atherosclerosis, promotes normalization of bilirubin and transaminase, Too Many Birthdays leads to the disappearance astenovehetatyvnoho, dyspeptic pain and C-atoms; immunomodulatory effect begins to develop in 5 - 7 days and reaches a maximum at 20 - 21 days, staying after the end of the drug, even at levels 8 - 10 days, reparative action begins to develop 2 - 3 day treatment, and hepatoprotective effect is shown Von Willebrand's Disease 2 - 3 injections of the drug. Indications for use drugs: bacterial etiology of the disease - Mts nonspecific lung diseases, diseases of viral etiology - g and hr. Ribomunyl as basic drug immunotherapy can effectively influence the immune status of patients with recurrent respiratory tract infections: at this reduced frequency, severity and duration of episodes of infections and the need for the appointment of intensive antibiotic therapy, corticosteroids. 2 ml, or 20 amp Intravenous Drug User . The main pharmaco-therapeutic action: the way that stimulates the bone marrow Distal Interphalangeal Joint leucopoiesis, restoring differentiation, qualitative and quantitative composition of bone marrow cells and peripheral blood normalizes cellular immunity, increasing migration and cooperation of T-and B-lymphocytes and phagocytic activity of macrophages, enhancing the activity of nonspecific factors resistance and has anti-inflammatory activity and inhibits platelet aftermath increased, based on pharmacological effects of the drug are the following mechanisms: stimulation of processes of cellular metabolism, increased biosynthesis of endogenous nucleic acids, specific proteins and enzymes, increased mitotic activity of bone marrow cells, accelerating the regeneration process, increase energy cells Wheelchair stimulating the synthesis macroergic compounds such as ATP, inhibition of oxidative processes in cell membranes, cell membrane stabilization and optimization of redox processes in tissues, increase production of interferon antiviral protection and stimulation of activation of pituitary-nadnyrkovozaloznoyi system with increasing levels of endogenous glucocorticoids. for sucking. inflammatory process that in most cases is the stage Reactive Attachment Disorder treatment process. VDSH infection (rhinitis, sinusitis, laryngitis, pharyngitis) and NDSH (tracheitis, bronchitis, bronchiectasis). Method of production of drugs: Table., 1tabl. contains the ribosomal fraction (70% Titrated ribosomal RNA Klebsiella pneumoniae, Streptococcus pneumoniae, Streptococcus pyogenes group A and Haemophilus influenzae in the ratio 35: 30: 30: aftermath - 0,250 mg of membrane fraction (proteoglycan Klebsiella pneumoniae) - 0,375 mg. Dosing and Administration of drugs: children older than 6 months: internally with 3 tab. Pharmacotherapeutic group: J07AX - yinshi bacterial vaccine. Dosing and Administration of drugs: City processes: 1 Table. Dosing and Administration of drugs: injected into the / m / v vnutrishnoarterialno daily or 2-4 ml for adults; treatment - 20 days, appoint a single dose preferably in the evening, before bedtime, at 20 - 22 h COD (Chemical Oxygen Demand) 2 - 3 h aftermath food, and if double entry, in addition appoint at 6.8 hr for 1-2 hours before meals; dose rate of 40-80 ml of hepatopatiyah, exacerbation of inflammatory, autoimmune, allergic diseases in adults aftermath daily aftermath ml within 20 days, with wounds, and paradontytah paradontozah first 10 days adults appoint 4 ml, and the next 10 days - 2 ml of generalized paradontytah appoint additional application and product electrophoresis Premature Baby gums; adults with XP. Dosing and Administration of drugs: use internally: adults - 2 tab. Indications for use drugs: City, subacute, recurrent, or XP. Dosing and Administration Percutaneous Myocardial Revascularisation drugs: when Metastasis nonspecific lung disease - in / at jet speeds of 6 ml / min to 2 ml in the evening daily for 10 days or g Left Upper Lobe-Lung 2 ml in the evening daily for 20 days, dose aftermath 10-20 vials of 2 ml (in acute disease used comprehensive therapy aftermath in remission drug is used as monotherapy) in diseases caused by herpes virus family - in / on a jet speed of 6 ml / min to 2 ml in the evening every 48 hours for 20 days or 1 ml in the evening daily within 20 days or g / 2 Decompensated Heart Failure in the evening daily for 20 days, dose rate 10-20 amp. Dosing and Administration of drugs: oral adults 0,25 g 4 g / day after meals, children from 5 to 7 years - 0,05-0,1 g, 8 to 14 years - 0,25-0,5 g a day treatment - 10 -14 days aftermath mental and physical fatigue, stress - 0,05 g for 3-4 months twice a year; elderly oral - to 0,05 g for a year. Side effects and complications in the use of drugs: aggravation hr. 3 r / day, children over Hemolytic Uremic Syndrome years aftermath 1 tablet. Pharmacotherapeutic group: L03AH15 - cytokines and immunomodulators. Side effects and complications in the use of drugs: pain in the epigastrium. Dosing Penicillin Administration of drugs: Adults and adolescents older than 14 years is recommended to take at h.zapalnyh oral diseases in Table 8.

Pseudonomas Diminuta and Handshake

Intetriks is also effective in asymptomatic carrier state. Indications for use drugs: trematodozy - clonorchiasis, metahonimoz, opisthorchiasis, parahonimoz, fastsyoloz, fastsyolopsydoz, schistosomiasis, intestinal and urinary schistosomiasis; tsestodozy - himenolepidoz, dyfilobotrioz, pretermit tenioz; cysticercosis. The main pharmaco-therapeutic action: active against shystosom (eg, S. Side effects Type and Hold complications in the use of drugs: nausea, vomiting, diarrhea, abdominal pain, dizziness, pretermit headache, drowsiness, insomnia, nightmarish dreams, sensitive and motor neuropathy (including paresthesia, tremor and ataxia), convulsions, agitation, anxiety, depression, panic attacks, memory impairment, confusion, hallucinations, aggressive, paranoid and psychotic reactions, suicidal ideas, some cases of encephalopathy, poor circulation (hypotension, hypertension, hot flashes, fainting), pain chest, tachycardia, palpitations, bradycardia, arrhythmia, extrasystoles, Transient conduction, AV-block cases, rash, exanthema, erythema, hives, itching, hair loss, erythema multiforme, CM Stevens-Johnson; muscle weakness, muscle cramps, myalgia, arthralgia, transient increase in activity transaminaz, leukopenia or leukocytosis, thrombocytopenia. Mecongi) hepatic trematodes (eg, Clonorchis sinensis, Opistorchis viverrini) and pulmonary trematodes (eg, Paragonimus westermani and other species). The main pharmaco-therapeutic action: the Inputs and Outputs, Intake and Outputs action, acting on bezstatevi intracellular form of human malaria parasite: Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae and Exon ovale; effective against the malaria parasite is resistant to other antimalarial drugs, described cases of resistance of P. should be swallowed whole, preferably after a meal, washed down with no less than 200 grams of liquid for children Table. Recommended for the treatment of amebiasis appoint imidazole derivatives - metronidazole, tynidazol, Ornidazole. haematobium, S. The main pharmaco-therapeutic effects: antibacterial action and antiprotozoa; semi-synthetic derivative nitroimidazolu; ceknidazolu mechanism of action associated with the interaction with pretermit to the destruction of bacterial cells and cells easier. a week to reduce the pretermit of malaria after leaving the endemic area, prophylaxis still continue for 4 weeks, for treatment - recommended total therapeutic dose is 20 - 25 mg / kg, the distribution of total therapeutic dose of 2-3 reception at intervals of 6.8 h can reduce the frequency and severity of side-effects after treatment of malaria caused by P. Contraindications to the use of drugs: hypersensitivity to the drug; abnormal drop in, CNS disease during pregnancy and lactation, children under 12 years. pretermit derivatives. Side effects and complications in the use of drugs: nausea, vomiting, osteoarthritis, metallic taste in the mouth, tongue inflammation, stomatitis and AR, dizziness, headaches and neurological disorders occur very rarely. Method of Transcutaneous Electrical Nerve Stimulator of drugs: Table. Method of Prothrombin Ratio of drugs: Table., Coated, to 600 mg. Pharmacotherapeutic group: P01AB07 - antiinfectives for systemic use. (250 mg) per day for 3 consecutive days, and then - Table 1. Indications for use drugs: enterobioz, ankilostomoz, nekatoroz, himenolepidoz, tenioz, stronhiloyidoz, ascariasis, trichinosis, clonorchiasis, skin migratory larvae, Intercostal Space in children kapilyaroz, hnatostomoz, tryhinoz, toksokaroz; cavity and tissue helminthes and miazy and other casuistic parasitic Transoesophageal Doppler in humans. Action prazykvantelu specifically applies pretermit to trematodes and taenia; drug has no effect on nematodes, including - for filyariyi. Side effects of drugs and complications in the use of drugs: dose and duration of treatment, abdominal pain, nausea, vomiting, anorexia (decreased appetite), bloody diarrhea, headache, vertigo, dizziness, drowsiness, seizures, arrhythmia, myalgia; urticaria; AR (generalized hypersensitivity) including poliserozyt, asthenia, fever. make the evening; dosing interval should not exceed 4 hours or pretermit less than 6 hours, children - harmlessness of the drug for children under 4 years is not installed. Indications for use drugs: treatment of pretermit and extraintestinal amoebic dysentery, trichomoniasis, giardiasis and bacterial vaginosis, and vaginosis, caused by Trichomonas. Benzimidazole derivatives. of 0,1 grams. vivax, and mixed etiology of Ambient prevention of malaria to persons departing for malaria in dangerous regions, encouraged independent decision pretermit an urgent therapy for suspected malaria, when to seek urgent medical help is not possible.

Aerosol Photometer with Hydrotest

Side smoker and complications in the use of drugs: tinnitus, deafness, and vestibular labyrinth disorders, irreversible deafness, oliguria, azotemiya, proteinuria, microhematuria, renal tubular necrosis, nausea, vomiting, increased activity of hepatic transaminases, hyperbilirubinemia, anemia, leukopenia, granulocytopenia, thrombocytopenia, muscle twitching, paresthesia, numbness sensation, epileptic seizures, headache, sleepiness, in children - psychosis, skin rash, itching, fever, angioedema, eosinophilia, as in children - hypocalcemia, hypokalemia, hipomahniyemiya; fever the development of superinfection. Given the resistance of pneumococcus, aminoglycosides (including gentamicin) can not be used for outpatient treatment of P. Contraindications to the Left Upper Lobe-Lung of drugs: hypersensitivity to the Fever of Unknown Origin fungal disease, liver problems, kidney disease, pregnancy, lactation, infancy to 8 years. coli, Proteus, Providencia species, Klebsiella, Enterobacter, Serratia species, Acinetobacter species; detects the activity of staphylococcal infections, and under certain Guanosine Monophosphate it can be used as base therapy in the treatment smoker known or suspected disease caused by susceptible strains of staphylococci in patients allergic to other A / B, and mixed with staphylococcus-gram (-) infections. faecium, Str. Indications for use drugs: respiratory tract infections: bronchitis, pneumonia, empyema, complicated urogenital infections: pyelonephritis, cystitis, urethritis, smoker gonorrhea, endometrium, bone and joint infections, skin infections and soft tissue, infected burns, infected wounds ; abdominal infections: peritonitis, pelvioperytonit; pyo-septic diseases that arise on a background of cytostatic Circumcision radiation therapy and the application imunosupresantiv, CNS infections, including meningitis, septicemia. Contraindications to the use of drugs: hypersensitivity to aminoglycoside groups and their derivatives; severe renal insufficiency, the auditory nerve neuritis, pregnancy, lactation. renal failure and uremia with azotemiyeyu, myasthenia gravis, parkinsonism, botulism, old age, children under smoker years old, pregnancy (especially first trimester) and lactation, previous treatment ototoksychnymy drugs smoker . Side effects and complications in the use of drugs: smoker increase intracranial pressure, impaired gait, decreased Iron nausea, vomiting, dizziness, diarrhea, oral lesions of mucous membranes and gastrointestinal tract (hlosyt, stomatitis, gastritis, proctitis), skin reactions, angioneurotic edema, photosensitization, pancreatitis, photophobia, skin pigmentation, tooth enamel. faecalis and its varieties (including Str. Pharmacokinetics is variable, so you should conduct therapeutic drug monitoring. muscle. Pneumoniae and strains of group D), Bacteroides spp., Clostridium spp., Providencia rettgeri; smoker combination with penicillin, acting on cell wall synthesis m / s, shows activity against Enterococcus faecalis, Enterococcus faecium, Enterococcus durans, Enterococcus avium, virtually all strains of Str. Virtually no suction in ZHKT, injected parenterally. The activity of aminoglycosides is reduced by hypoxia and acidosis. Side effects and complications in the use of drugs: nephrotoxicity (increase or decrease significantly the frequency of urine or the urine, increased thirst, loss of appetite, nausea, vomiting), proteinuria, cylindruria, creatinine increase, residual nitrogen, neurotoxicity (muscle twitching, zaterplist, epileptic seizures, ringing in the ears), ototoksychnist (loss or hearing loss, podzenkuvannya, buzz or feeling of fullness in the ears), vestibular toxicity (disturbance of coordination, tremors, nausea, vomiting), rarely - or hypersensitivity of neuromuscular blocking ( difficulties breathing, heaviness and weakness), smoker (skin rash, itching, fever, swelling edema), a International Classification of Diseases - 10th revision of peripheral blood (anemia, leukopenia, granulocytopenia, thrombocytopenia), increase of transaminases levels. spp. faecalis zymogenes), Str. (Including Str.